Source:http://linkedlifedata.com/resource/pubmed/id/10332054
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1999-7-13
|
pubmed:abstractText |
Octreotide (octreotide-acetate, Sandostatin(R)) is a somatostatin analogue, used in long-term treatment of acromegaly. The present study describes the absorption profile in rabbits of octreotide after release from the long-acting formulation OncoLAR (denoted as octreotide-LAR). In a first experiment, the disposition kinetics of octreotide was studied for 24 h in six rabbits after intravenous (i. v.) injection of 0.025 mg of a solution of octreotide. In a second experiment, release kinetics was studied in eight rabbits for 49 days after an i.m. injection of 5 mg/kg of octreotide-LAR. Concentrations were determined by radioimmunoassay. After i.v. injection of octreotide, one- and two-compartment models were compared for each rabbit. A typical disposition profile was computed using the mean parameters. After i.m. injection of octreotide-LAR, deconvolution was performed using the point-area method. Individual absorption profiles were characterised using natural splines. The number of breakpoints was selected using the generalised cross-validation criterion. The two compartment model was selected based on the i.v. study. After i.m. administration, octreotide exhibited a triphasic absorption profile, with large interindividual variability. A transient peak followed the initial burst phase. The third phase covered 85% of total drug released. The approach allows a model-independent description of the in vivo absorption profile of octreotide-LAR.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0168-3659
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
197-205
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10332054-Absorption,
pubmed-meshheading:10332054-Animals,
pubmed-meshheading:10332054-Delayed-Action Preparations,
pubmed-meshheading:10332054-Hormones,
pubmed-meshheading:10332054-Infusions, Intravenous,
pubmed-meshheading:10332054-Injections, Intramuscular,
pubmed-meshheading:10332054-Male,
pubmed-meshheading:10332054-Octreotide,
pubmed-meshheading:10332054-Rabbits,
pubmed-meshheading:10332054-Regression Analysis,
pubmed-meshheading:10332054-Reproducibility of Results
|
pubmed:year |
1999
|
pubmed:articleTitle |
Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR.
|
pubmed:affiliation |
Inserm U 436, CHU Pitié-Salpêtrière, 91 Bd de l'Hôpital, 75-013 Paris, France. eco@biomath.jussieu.fr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|